Dominic Schmidt

Dominic Schmidt

Partner

Dominic is a Partner of Syncona Investment Management Ltd.

He is a a Director on the board of Anaveon, and Purespring Therapeutics.

Prior to joining Syncona, Dominic worked in the life science practice of strategy consultancy L.E.K Consulting. He received his PhD from the Department of Oncology at the University of Cambridge where he was a Cancer Research UK scholar. He also holds a German Diplom Degree in Biochemistry and his research has been honoured with national and international prizes and published in Cell, Nature and Science.

Syncona portfolio companies

  • Freeline Therapeutics
  • Gyroscope Therapeutics
  • Purespring Therapeutics (Board member)
  • Anaveon (Board member)
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Freddie Dear

Freddie Dear

Partner
Kenneth Galbraith

Kenneth Galbraith

Executive in Residence
Lorenz Mayr

Lorenz Mayr

Entrepreneur in Residence
Elisa Petris

Elisa Petris

Partner
Alice Renard

Alice Renard

Partner